LOXAPAC TAB 50MG DIN 00346810
Health Canada record
| Active ingredient(s) | LOXAPINE SUCCINATE 68 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AH01 LOXAPINE |
| Original market date | 31-Dec-1976 |
| Current status date | 14-Aug-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LOXAPINE SUCCINATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00439819 | LOXAPAC INJ 50MG/ML | LEDERLE CYANAMID CANADA INC. | Liquid | LOXAPINE SUCCINATE 50 MG | Cancelled Post Market |
| 00346799 | LOXAPAC TAB 10MG | LEDERLE CYANAMID CANADA INC. | Tablet | LOXAPINE SUCCINATE 13.6 MG | Cancelled Post Market |
| 00346802 | LOXAPAC TAB 25MG | LEDERLE CYANAMID CANADA INC. | Tablet | LOXAPINE SUCCINATE 34 MG | Cancelled Post Market |
| 00346780 | LOXAPAC TAB 5MG | LEDERLE CYANAMID CANADA INC. | Tablet | LOXAPINE SUCCINATE 6.8 MG | Cancelled Post Market |
International API supply for LOXAPINE SUCCINATE
2 active FDA Drug Master Files.
Request a quote for LOXAPAC TAB 50MG